Crispr Therapeutics shares tumble after significant earnings miss
Harris Arno Lockheart, a director at PG&E Corp (NYSE:PCG), has made a significant purchase of the company’s stock, according to a recent SEC filing. On February 20, Lockheart acquired 6,389 shares of PG&E common stock at a price of $15.66 per share, amounting to a total transaction value of approximately $100,051. This acquisition was made through the Harris Living Trust, following which Lockheart’s direct and indirect ownership of PG&E shares totals 73,226.58 shares.
In other recent news, PG&E Corporation reported its fourth-quarter earnings for 2024, revealing a slight miss on earnings per share (EPS) and revenue forecasts. The company posted an EPS of $0.31, slightly below the expected $0.32, and reported revenues of $6.63 billion, falling short of the forecasted $7.19 billion. Despite these results, PG&E achieved an 11% year-over-year increase in core EPS for the full year, reaching $1.36. Looking ahead, PG&E has adjusted its 2025 EPS guidance, with a new range of $1.48 to $1.52, indicating confidence in its operational strategies. Additionally, PG&E completed a $2.75 billion equity offering in December, which supports its capital investment plans through 2028. BMO Capital Markets recently raised PG&E’s stock price target to $23, maintaining an Outperform rating, reflecting confidence in the company’s operational performance. The analyst at BMO cited PG&E’s consistent performance and updated guidance as reasons for the positive outlook. These developments come as PG&E continues to focus on expanding its data center load pipeline and implementing grid safety measures.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.